{"id":842342,"date":"2022-12-13T18:00:58","date_gmt":"2022-12-13T17:00:58","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/"},"modified":"2022-12-13T18:00:58","modified_gmt":"2022-12-13T17:00:58","slug":"peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/","title":{"rendered":"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury"},"content":{"rendered":"\u2013 Proceeds to advance lead program into clinical development\u2013\n\n\n\u2013 Financing Led by Perceptive Xontogeny Venture Fund\u2013\n\nPHILADELPHIA--(BUSINESS WIRE)--Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (\u201cPXV Fund\u201d). The company will use the proceeds to build upon the preclinical work conducted through collaborative partnership and seed investment with the Xontogeny development team to advance the lead candidate, PIP-2, through IND-enabling studies and into clinical development.\n\n\n\n\u201cThe data generated to date for PIP-2 represents a poten<div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>\u2013 Proceeds to advance lead program into clinical development\u2013 \u2013 Financing Led by Perceptive Xontogeny Venture Fund\u2013 PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211;Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (\u201cPXV [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-842342","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury - BeBeez\" \/>\n<meta property=\"og:description\" content=\"\u2013 Proceeds to advance lead program into clinical development\u2013 \u2013 Financing Led by Perceptive Xontogeny Venture Fund\u2013 PHILADELPHIA--(BUSINESS WIRE)--Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (\u201cPXV [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-13T17:00:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury\",\"datePublished\":\"2022-12-13T17:00:58+00:00\",\"dateModified\":\"2022-12-13T17:00:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\"},\"wordCount\":733,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\",\"name\":\"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-12-13T17:00:58+00:00\",\"dateModified\":\"2022-12-13T17:00:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/","og_locale":"en_US","og_type":"article","og_title":"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury - BeBeez","og_description":"\u2013 Proceeds to advance lead program into clinical development\u2013 \u2013 Financing Led by Perceptive Xontogeny Venture Fund\u2013 PHILADELPHIA--(BUSINESS WIRE)--Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (\u201cPXV [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/","og_site_name":"BeBeez","article_published_time":"2022-12-13T17:00:58+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/"},"author":{"name":"","@id":""},"headline":"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury","datePublished":"2022-12-13T17:00:58+00:00","dateModified":"2022-12-13T17:00:58+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/"},"wordCount":733,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/","name":"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-12-13T17:00:58+00:00","dateModified":"2022-12-13T17:00:58+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/peroxitech-announces-closing-of-25m-series-a-financing-to-develop-novel-treatment-for-acute-lung-injury\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/842342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=842342"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/842342\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=842342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=842342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=842342"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=842342"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=842342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}